Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
With Nuvalent takeout complete, GSK wins its first FDA OK for a lung cancer drug
1+ hour, 21+ min ago (17+ words) FirstWord Pharma...
Arrowhead looses late-stage Redemplo data in sHTG, setting up head-to-head with Ionis
3+ hour, 2+ min ago (17+ words) FirstWord Pharma...
Summit touts new analysis supporting ivonescimab's survival benefit in Western patients
4+ hour, 42+ min ago (13+ words) FirstWord Pharma...
Physician Views Preview: Wegovy pill approved in Europe — are clinicians ready to use it?
6+ hour, 57+ min ago (16+ words) FirstWord Pharma...
Trump's latest tariff proposal seeks to reshore generic drug production
7+ hour, 34+ min ago (12+ words) FirstWord Pharma...
Novo sues Lilly over 'pattern of deceptive advertising' in GLP-1 ads
1+ day, 9+ hour ago (14+ words) FirstWord PHARMA...
Spotlight On: Updated Physician Views poll data shows particularly strong support for Merck & Co.'s Lipfendra from US cardiologists
1+ day, 12+ hour ago (22+ words) FirstWord PHARMA...
Novartis returns to growth on second-quarter performance of key drugs
1+ day, 15+ hour ago (13+ words) FirstWord PHARMA...
Samsung Biologics moves to enter peptide space with $1.8B PolyPeptide buy
2+ day, 3+ hour ago (13+ words) FirstWord PHARMA...
Kolon's cell-based gene therapy faces another test after Phase III letdown
2+ day, 7+ hour ago (14+ words) FirstWord PHARMA...